These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 1884319)

  • 1. Cystic fibrosis. Infection, immunopathology, and host response.
    Clin Rev Allergy; 1991; 9(1-2):1-247. PubMed ID: 1884319
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis.
    Marshall BC; Carroll KC
    Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis.
    Brouard J; Knauer N; Boelle PY; Corvol H; Henrion-Caude A; Flamant C; Bremont F; Delaisi B; Duhamel JF; Marguet C; Roussey M; Miesch MC; Chadelat K; Boule M; Fauroux B; Ratjen F; Grasemann H; Clement A
    J Infect Dis; 2005 Jun; 191(11):1988-91. PubMed ID: 15871134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Respiratory infection in cystic fibrosis: burden of illness in the progression of cystic fibrosis, previous deductions for the microbiological study of bronchial secretions and clinical criteria of infection].
    Thumerelle C
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S37-48. PubMed ID: 12910133
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
    Bauernfeind A; Przyklenk B
    Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
    [No Abstract]   [Full Text] [Related]  

  • 6. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial colonization and infection in the CF lung.
    Sagel SD; Dowell EB; Accurso FJ
    Methods Mol Med; 2002; 70():433-46. PubMed ID: 11917541
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Kerrebijn KF; Mouton J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):28-33. PubMed ID: 2130712
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients.
    Lang AB; Horn MP; Imboden MA; Zuercher AW
    Vaccine; 2004 Dec; 22 Suppl 1():S44-8. PubMed ID: 15576201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some immunologic considerations of chronic pulmonary infection in cystic fibrosis.
    Gifford RR
    J S C Med Assoc; 1972 May; 68(5):204-7. PubMed ID: 4554120
    [No Abstract]   [Full Text] [Related]  

  • 12. Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem?
    Holland DJ; Wesley A; Drinkovic D; Currie BJ
    Clin Infect Dis; 2002 Dec; 35(12):e138-40. PubMed ID: 12471591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What is the burden of respiratory infection in the progression of cystic fibrosis].
    Bellon G
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S49-55. PubMed ID: 12910134
    [No Abstract]   [Full Text] [Related]  

  • 15. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
    De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
    Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic polyarthritis in cystic fibrosis].
    De Lumley L; Umdenstock R; Boulesteix J; Labrousse C; Simon G
    Arch Fr Pediatr; 1983 Nov; 40(9):723-5. PubMed ID: 6667096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of staphylococcal infection in cystic fibrosis].
    Sermet-Gaudelus I
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S91-9. PubMed ID: 12910140
    [No Abstract]   [Full Text] [Related]  

  • 18. IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Pressler T
    APMIS Suppl; 1996; 66():1-41. PubMed ID: 8972694
    [No Abstract]   [Full Text] [Related]  

  • 19. Cross-infection with Pseudomonas aeruginosa among patients with cystic fibrosis.
    Agarwal G; Kapil A; Kabra SK; Das BK
    Natl Med J India; 2006; 19(4):236-7. PubMed ID: 17103494
    [No Abstract]   [Full Text] [Related]  

  • 20. Inflammation in cystic fibrosis--when and why? Friend or foe?
    Elston C; Geddes D
    Semin Respir Crit Care Med; 2007 Jun; 28(3):286-94. PubMed ID: 17562498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.